Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Jan 15, 2025; 17(1): 100204
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.100204
Table 2 Characteristics of study participants
Characteristics
All patients
Propensity-matched patients
Control, n = 1034
CRC, n = 277
P value
Controls, n = 207
CRC, n = 207
P value
Age in years66.53 ± 7.4166.54 ± 10.910.98968.89 ± 5.5365.58 ± 11.120.053
Sex as male/female466/568176/101< 0.00196/111122/850.010
Hypertension in %10.2543.68< 0.00134.7828.990.206
Diabetes in %1.6414.80< 0.0017.735.800.434
Coronary heart disease or Cerebral infarction in %0.48%12.64< 0.0012.242.241
BMI25.09 ± 5.2523.78 ± 3.27< 0.00124.40 ± 3.7723.84 ± 3.290.106
WBC as × 109/L6.49 ± 1.586.16 ± 1.840.0036.64 ± 1.666.14 ± 1.840.004
RBC as × 109/L4.70 ± 0.434.19 ± 0.61< 0.0014.66 ± 0.404.21 ± 0.58< 0.001
Hb in g/L143.23 ± 13.24120.63 ± 25.73< 0.001141.89 ± 12.61121.47 ± 25.08< 0.001
PLT as × 109/L216.94 ± 52.78240.59 ± 83.72< 0.001224.17 ± 51.69240.94 ± 78.970.011
ALT in U/L21.36 ± 7.7518.50 ± 31.600.14420.33 ± 7.6317.65 ± 18.270.057
AST in U/L21.40 ± 12.6521.24 ± 35.770.90819.36 ± 12.6019.73 ± 11.930.758
TC in mmol/L4.81 ± 0.984.23 ± 0.97< 0.0014.80 ± 1.024.34 ± 0.94< 0.001
TG in mmol/L1.65 ± 1.211.35 ± 0.73< 0.0011.84 ± 1.871.33 ± 0.65< 0.001
HDL-C in mmol/L1.38 ± 0.361.14 ± 0.32< 0.0011.41 ± 0.411.17 ± 0.32< 0.001
LDL-C in mmol/L3.10 ± 0.872.66 ± 0.85< 0.0013.01 ± 0.862.76 ± 0.830.003
UA in mmol/L319.84 ± 77.29315.62 ± 81.370.430324.75 ± 80.97312.42 ± 78.700.121
SCR in mmoI/L74.63 ± 22.8976.67 ± 21.080.19078.29 ± 26.1073.84 ± 19.890.056
CEA in ng/mL1.91 ± 1.5135.67 ± 176.150.0022.80 ± 1.5426.62 ± 95.890.001
CA199 in U/mL11.26 ± 7.64176.16 ± 1013.410.00912.00 ± 8.77159.62 ± 929.850.027
AI2.65 ± 1.0535.67 ± 176.150.0022.64 ± 1.352.89 ± 1.140.042
TyG index8.81 ± 0.588.58 ± 0.55< 0.0018.86 ± 0.598.55 ± 0.51< 0.001